HUE051549T2 - Di (fenilpropanoid) glicerin származékai rák kezelésére - Google Patents

Di (fenilpropanoid) glicerin származékai rák kezelésére

Info

Publication number
HUE051549T2
HUE051549T2 HUE10821532A HUE10821532A HUE051549T2 HU E051549 T2 HUE051549 T2 HU E051549T2 HU E10821532 A HUE10821532 A HU E10821532A HU E10821532 A HUE10821532 A HU E10821532A HU E051549 T2 HUE051549 T2 HU E051549T2
Authority
HU
Hungary
Prior art keywords
phenylpropanoid
cancer
treatment
glycerol derivatives
glycerol
Prior art date
Application number
HUE10821532A
Other languages
English (en)
Hungarian (hu)
Inventor
Alexander Macgregor
Original Assignee
Alexander Macgregor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alexander Macgregor filed Critical Alexander Macgregor
Publication of HUE051549T2 publication Critical patent/HUE051549T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734Ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/16Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
HUE10821532A 2009-10-09 2010-10-08 Di (fenilpropanoid) glicerin származékai rák kezelésére HUE051549T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25028709P 2009-10-09 2009-10-09

Publications (1)

Publication Number Publication Date
HUE051549T2 true HUE051549T2 (hu) 2021-10-28

Family

ID=43352967

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE10821532A HUE051549T2 (hu) 2009-10-09 2010-10-08 Di (fenilpropanoid) glicerin származékai rák kezelésére

Country Status (20)

Country Link
US (2) US9061993B2 (https=)
EP (1) EP2486026B1 (https=)
JP (1) JP5529280B2 (https=)
CN (1) CN102264713A (https=)
BR (1) BR112012008204A2 (https=)
CA (1) CA2715662C (https=)
CY (1) CY1123161T1 (https=)
DK (1) DK2486026T3 (https=)
ES (1) ES2810906T3 (https=)
HR (1) HRP20201217T1 (https=)
HU (1) HUE051549T2 (https=)
LT (1) LT2486026T (https=)
MX (1) MX360417B (https=)
MY (2) MY160378A (https=)
PL (1) PL2486026T3 (https=)
PT (1) PT2486026T (https=)
RS (1) RS60667B1 (https=)
SI (1) SI2486026T1 (https=)
SM (1) SMT202000428T1 (https=)
WO (1) WO2011041907A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8907117B2 (en) * 2011-09-08 2014-12-09 Henry Lowe Anti-tumor and anti-inflammatory dicinnamoyl-glycerol esters and their analogues
US9907786B2 (en) 2014-10-21 2018-03-06 Ions Pharmaceutical S.À R.L. Therapeutic compositions containing harmine and isovanillin components, and methods of use thereof
US10092550B2 (en) 2014-10-21 2018-10-09 Ions Pharmaceutical S.À R.L. Therapeutic compositions containing curcumin, harmine, and isovanillin components, and methods of use thereof
US20160106687A1 (en) 2014-10-21 2016-04-21 Life Plus, LLC Human therapeutic agents
US12129265B2 (en) 2020-07-21 2024-10-29 Ankh Life Sciences Limited Therapeutic agents and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3857873A (en) 1974-02-11 1974-12-31 Warner Lambert Co 3-hydroxy-5-(3-(substituted-amino)-2-hydroxypropoxy)-benzyl alcohols
CH648753A5 (de) * 1981-07-22 1985-04-15 Givaudan & Cie Sa Lichtschutzmittel.
CN1238333C (zh) * 2003-06-18 2006-01-25 清华大学 药物化合物菠萝酰酯及其制备方法和用途
US7713556B2 (en) 2006-12-08 2010-05-11 Henry Lowe Anti-tumor and anti-inflammatory extracts of plant biomass and their uses
JP2010515685A (ja) * 2007-01-08 2010-05-13 アンドロサイエンス コーポレーション (置換フェニル)−プロペナール部分を伴う化合物、その誘導体、生物学的活性およびその使用
TWI383251B (zh) * 2008-01-16 2013-01-21 Eternal Chemical Co Ltd 感光型聚醯亞胺
KR101074149B1 (ko) * 2009-04-15 2011-10-17 한밭대학교 산학협력단 신규 폴리페놀/폴리페놀 컨쥬게이트 화합물 및 그의 용도
US8907117B2 (en) * 2011-09-08 2014-12-09 Henry Lowe Anti-tumor and anti-inflammatory dicinnamoyl-glycerol esters and their analogues

Also Published As

Publication number Publication date
CY1123161T1 (el) 2021-10-29
ES2810906T3 (es) 2021-03-09
LT2486026T (lt) 2020-09-10
US10052301B2 (en) 2018-08-21
JP5529280B2 (ja) 2014-06-25
US9061993B2 (en) 2015-06-23
EP2486026B1 (en) 2020-06-24
EP2486026A4 (en) 2015-07-01
CA2715662C (en) 2013-05-07
MX360417B (es) 2018-10-25
SMT202000428T1 (it) 2020-09-10
WO2011041907A1 (en) 2011-04-14
JP2013507327A (ja) 2013-03-04
EP2486026A1 (en) 2012-08-15
HRP20201217T1 (hr) 2020-12-11
CN102264713A (zh) 2011-11-30
MY160378A (en) 2017-03-15
PT2486026T (pt) 2020-08-21
US20150246014A1 (en) 2015-09-03
RS60667B1 (sr) 2020-09-30
PL2486026T3 (pl) 2020-11-02
CA2715662A1 (en) 2010-12-14
MX2012004160A (es) 2012-09-07
US20110086912A1 (en) 2011-04-14
DK2486026T3 (da) 2020-08-17
BR112012008204A2 (pt) 2017-07-18
MY187188A (en) 2021-09-09
SI2486026T1 (sl) 2020-10-30

Similar Documents

Publication Publication Date Title
IL223201A (en) Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer
DK3289876T3 (da) Forbindelser til behandling af cancer
BR112012005594A2 (pt) tratamento de câncer
HUE054495T2 (hu) Rák kezelésére szolgáló készítmény
HRP20150477T8 (hr) Postupci dobivanja derivata kinazolona
DK2121139T3 (da) Formulations for cancer treatment
DK2195015T3 (da) Sammensætning til behandling af prostatacancer
PL2733492T3 (pl) Sposób wykrywania nowotworów
EP2460538A4 (en) TUMOR METASTASIS INHIBITORS
DK3517534T3 (da) Forbindelser, der er anvendelige til behandling af cancer
PL3443957T3 (pl) Związki i kompozycje stosowane w leczeniu nowotworów
BRPI1010874A8 (pt) composição para o tratamento de câncer de próstata
BRPI1007972A2 (pt) composições de combinação e métodos para o tratamento de câncer
DK2452189T3 (da) Fremgangsmåde til identifikation af forbindelser til behandling af cancer
IL220386B (en) Compositions for the liquidation of tumors and uses thereof
DK3246042T3 (da) Lægemiddelresistent immunterapi til behandling af cancer
BRPI1007995A2 (pt) orto-aminoamidas para o tratamento de cãncer.
BR112012002797A2 (pt) tratamento de câncer de próstata
IL226246A0 (en) Methods of treating cancer
SMT201600076B (it) Derivati di 2-osso-1-pirrolidinil imidazotiadiazolo
EP2283862A4 (en) ANTITUMOR AGENT
HUE038563T2 (hu) Rák kezelési eljárás
BRPI1009435A2 (pt) tratamento para câncer no pâncreas
HUE051549T2 (hu) Di (fenilpropanoid) glicerin származékai rák kezelésére
PL2467140T3 (pl) Lapatynib do leczenia raka